Pacira BioSciences: Q1 Earnings Insights

Comments
Loading...

 

Pacira BioSciences PCRX reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Pacira BioSciences missed estimated earnings by 22.89%, reporting an EPS of $0.64 versus an estimate of $0.83.

Revenue was up $38.96 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 4.89% increase in the share price the next day.

Here's a look at Pacira BioSciences's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.90 0.65 0.69 0.63
EPS Actual 0.97 0.72 0.77 0.53
Revenue Estimate 155.74M 130.38M 128.01M 119.28M
Revenue Actual 159.19M 127.72M 135.59M 119.03M

To track all earnings releases for Pacira BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

PCRX Logo
PCRXPacira BioSciences Inc
$22.47-2.98%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum89.04
Growth46.80
Quality24.62
Value61.60
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: